Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP
Professor of Pharmacy Practice
Pharmacy Clinical & Admin Sci
Phone (405) 271-2730
Fax (405) 271-6750
Office O'Donoghue Research Bldg; 1122 NE 13th St., Ste. 4415, OKC 73117
- President's Associate Presidential Professor
- Director, PGY2 Pediatric Pharmacy Residency
- Director, Pediatric Pharmacotherapy Degree Option
Publications & Presentations
- 1. Bradford C V, Miller J L, Ranallo C D, Neely S, Johnson P N. Vasopressin-Induced Hyponatremia in Infants Following Cardiovascular Surgery. The Annals of pharmacotherapy. 2023; 57 : 259-266
2. Chang E, Ballard K E, Johnson P N, Nandyal R, Miller J L. Azithromycin for Eradication of Ureaplasma and Prevention of Bronchopulmonary Dysplasia in Preterm Neonates in the Neonatal Intensive Care Unit. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2023; 28 : 10-19
3. Hintze T D, Miller J L, Neely S, Lim S Y, Gupta N, Johnson P N. Characterization of early versus late opioid iatrogenic withdrawal syndrome in critically ill children transitioning from fentanyl -infusions to methadone. Journal of opioid management. 2023; 19 : 43-56
4. Mayes R A, Johnson P N, White B P, Neely S, Chaaban H, Miller J L. Evaluation of Ceftazidime Use in the Neonatal Intensive Care Unit and Association With Cephalosporin-Resistant Gram-Negative Bacteria. The Annals of pharmacotherapy. 2022; 56 : 1325-1332
5. Bennett K, Fox A, Miller J, Neely S, Dennis V C, Johnson P. Publication Rates of Pharmacy Residents Involved in a Team-Based Research Program. American Journal of Health-System Pharmacy. 2022; 79 : 2141-2149
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 6. University of Oklahoma College of Medicine, Department of Pediatrics. Best Trainee Research Award (Served as resident mentor). Date: 2015.
7. ACCP Pediatric Practice and Research Network. Travel Award (Served as student mentor). Date: 2014.
8. Pediatric Pharmacy Advocacy Group. Original Research Award. Date: 2014.
9. University of Kentucky College of Pharmacy. Rho Chi Research Symposium--1st Place Award Winner. Date: 2006.
- 1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.
2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.
3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.
4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.